Certain Immune Cells Play Crucial Role in Immunotherapy Response, Study Suggests – Specialty Pharmacy Times
|
Certain Immune Cells Play Crucial Role in Immunotherapy Response, Study Suggests
Specialty Pharmacy Times The study was an extension of the complete CheckMate 141 phase 3 clinical trial, which showed that the immunotherapy nivolumab (Opdivo) significantly increased survival and had fewer adverse events in patients with recurrent head and neck cancer. |
